Stock listing

Verrica Pharmaceuticals Inc.

Selected listing: A41A98 · LS · EUR · DE

Verrica Pharmaceuticals Inc. (Lang & Schwarz: A41A98), Health Technology. Latest release Sep 30, 2026: Verrica Pharmaceuticals to Present New YCANTH® Data…

A41A98:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A41A98
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences

September 29, 2026

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences

September 30, 2026

Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences

September 10, 2026

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 8, 2026

Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027

August 27, 2026

All Verrica Pharmaceuticals Inc. news →

Events

Replays

Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
Verrica Pharmaceuticals Inc. (VRCA) Q1 2026 Earnings Call
Tue, May 12, 2026 · 04:30 PM ET
Watch
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call
Wed, Mar 11, 2026 · 08:15 AM ET
Watch

Research Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. company profile

View the public company page for Verrica Pharmaceuticals Inc. on 6ix.

Verrica Pharmaceuticals Inc. news

Read company news and market updates connected to Verrica Pharmaceuticals Inc..

Verrica Pharmaceuticals Inc. investor events

Find investor webinars, events, and replay context for Verrica Pharmaceuticals Inc..